DPPE-PEG-Mal, with a MW of 3.4K, is a notable compound in pharmaceutical R&D, combining dipalmitoylphosphatidylethanolamine (DPPE) and polyethylene glycol (PEG) for drug delivery. Its maleimide group selectively reacts with cysteine’s sulfhydryl, essential for targeted drug delivery. This compound serves as a linker for drug and targeting molecules, offering improved solubility, enhanced bioavailability, and reduced toxicity by ensuring specific targeting.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.